How many insider declarations does 易明医药 have?

易明医药 has filed 4 insider declarations with AMF.

Who is the top reporting insider at 易明医药?

The top reporting insider at 易明医药 is 许可, based on the count of public filings.

What is the net insider buy vs sell volume on 易明医药?

Across the available history, declared buys total 0 and disposals 0.

InsidersTradesSigma

← Companies ★ Sign in to follow

易明医药: insider trades · France · AMF

SZSE:002826FR·AMFMcap 3.5Bn€

AMF ↗

Discover the full insider trade history of 易明医药, a listed issuer based in France. Shares are listed on FR FR, under the authority of AMF. Market capitalisation: €3.5bn. The latest transaction was reported on 7 May 2025 — Sale. Among the most active insiders: 许可. The full history is free.

4

Insider Decl.

0

Thresholds

·

0 ops.

Buy Volume

·

4 ops.

Sell Volume

Financial data

FY ended December 2025 · cache

18.73 €

Income statement

Revenue636.3 M€

Gross profit522.5 M€82% margin

Net income92.6 M€14.6% margin

Balance sheet & cash

Market cap3.50 Bn€

Total debt11.3 M€

Free Cash Flow115.2 M€

Last declaration on 7 May 2025

All Executives4 Thresholds Prospectus Other

Declarations0 total

No declarations found

0 of 0 declarations